Noncanonical Pathway for Regulation of CCL2 Expression by an mTORC1-FOXK1 Axis Promotes Recruitment of Tumor-Associated Macrophages
Noncanonical Pathway for Regulation of CCL2 Expression by an mTORC1-FOXK1 Axis Promotes Recruitment of Tumor-Associated Macrophages
复制标题
DOI:
10.1016/j.celrep.2017.11.014
复制
发表时间:
2017-11-28
期刊:
影响因子:
8.8
通讯作者:
Nakayama, Keiichi I.
中科院分区:
文献类型:
--
作者:
Nakatsumi, Hirokazu;Matsumoto, Masaki;Nakayama, Keiichi I.
C-C chemokine ligand 2 (CCL2) plays pivotal roles in tumor formation, progression, and metastasis. Although CCL2 expression has been found to be dependent on the nuclear factor (NF)-kappa B signaling pathway, the regulation of CCL2 production in tumor cells has remained unclear. We have identified a non-canonical pathway for regulation of CCL2 production that is mediated by mammalian target of rapamycin complex 1 (mTORC1) but independent of NF-kappa B. Multiple phosphoproteomics approaches identified the transcription factor forkhead box K1 (FOXK1) as a downstream target of mTORC1. Activation of mTORC1 induces dephosphorylation of FOXK1, resulting in transactivation of the CCL2 gene. Inhibition of the mTORC1-FOXK1 axis attenuated insulin-induced CCL2 production as well as the accumulation of tumor-associated monocytes-macrophages and tumor progression in mice. Our results suggest that FOXK1 directly links mTORC1 signaling and CCL2 expression in a manner independent of NF-kB and that CCL2 produced by this pathway contributes to tumor progression.